Loading company…
SynBioLab develops engineered microbial strains and cell factories for pharmaceutical, chemical, and agricultural companies.
Founded in 2017 in Jiaxing, China, SynBioLab provides strain improvement and industrialization services, developing microbial cell factories to produce drugs and chemical raw materials. It earns revenue from engineering strain design and optimization services. In July 2025, it closed a venture funding round from Changde Caixin Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in